164 related articles for article (PubMed ID: 20460118)
1. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains.
Feuillette S; Deramecourt V; Laquerriere A; Duyckaerts C; Delisle MB; Maurage CA; Blum D; Buée L; Frébourg T; Campion D; Lecourtois M
Brain Res; 2010 Jul; 1345():182-9. PubMed ID: 20460118
[TBL] [Abstract][Full Text] [Related]
2. Fyn depletion ameliorates tau
Liu G; Fiock KL; Levites Y; Golde TE; Hefti MM; Lee G
Acta Neuropathol Commun; 2020 Jul; 8(1):108. PubMed ID: 32665013
[TBL] [Abstract][Full Text] [Related]
3. Targeting tau: Clinical trials and novel therapeutic approaches.
VandeVrede L; Boxer AL; Polydoro M
Neurosci Lett; 2020 Jul; 731():134919. PubMed ID: 32380145
[TBL] [Abstract][Full Text] [Related]
4. Tau Protein and Frontotemporal Dementias.
Goedert M; Spillantini MG; Falcon B; Zhang W; Newell KL; Hasegawa M; Scheres SHW; Ghetti B
Adv Exp Med Biol; 2021; 1281():177-199. PubMed ID: 33433876
[TBL] [Abstract][Full Text] [Related]
5. Behind the curtain of tauopathy: a show of multiple players orchestrating tau toxicity.
Huang Y; Wu Z; Zhou B
Cell Mol Life Sci; 2016 Jan; 73(1):1-21. PubMed ID: 26403791
[TBL] [Abstract][Full Text] [Related]
6. Human iPSC 4R tauopathy model uncovers modifiers of tau propagation.
Parra Bravo C; Giani AM; Madero-Perez J; Zhao Z; Wan Y; Samelson AJ; Wong MY; Evangelisti A; Cordes E; Fan L; Ye P; Zhu D; Pozner T; Mercedes M; Patel T; Yarahmady A; Carling GK; Sterky FH; Lee VMY; Lee EB; DeTure M; Dickson DW; Sharma M; Mok SA; Luo W; Zhao M; Kampmann M; Gong S; Gan L
Cell; 2024 May; 187(10):2446-2464.e22. PubMed ID: 38582079
[TBL] [Abstract][Full Text] [Related]
7. Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer's disease, progressive supranuclear palsy and dementia with Lewy bodies.
Puangmalai N; Bhatt N; Montalbano M; Sengupta U; Gaikwad S; Ventura F; McAllen S; Ellsworth A; Garcia S; Kayed R
Cell Death Dis; 2020 May; 11(5):314. PubMed ID: 32366836
[TBL] [Abstract][Full Text] [Related]
8. Tau-RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change.
McMillan PJ; Benbow SJ; Uhrich R; Saxton A; Baum M; Strovas T; Wheeler JM; Baker J; Liachko NF; Keene CD; Latimer CS; Kraemer BC
Brain; 2023 Aug; 146(8):3206-3220. PubMed ID: 36732296
[TBL] [Abstract][Full Text] [Related]
9. Tau-Induced Elevation of the Activity-Regulated Cytoskeleton Associated Protein Arc1 Causally Mediates Neurodegeneration in the Adult Drosophila Brain.
Schulz L; Ramirez P; Lemieux A; Gonzalez E; Thomson T; Frost B
Neuroscience; 2023 May; 518():101-111. PubMed ID: 35487302
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic tau-induced transposable element-derived dsRNA drives neuroinflammation.
Ochoa E; Ramirez P; Gonzalez E; De Mange J; Ray WJ; Bieniek KF; Frost B
Sci Adv; 2023 Jan; 9(1):eabq5423. PubMed ID: 36608133
[TBL] [Abstract][Full Text] [Related]
11. The homologous carboxyl-terminal domains of microtubule-associated protein 2 and TAU induce neuronal dysfunction and have differential fates in the evolution of neurofibrillary tangles.
Xie C; Miyasaka T; Yoshimura S; Hatsuta H; Yoshina S; Kage-Nakadai E; Mitani S; Murayama S; Ihara Y
PLoS One; 2014; 9(2):e89796. PubMed ID: 24587039
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in a
Bukhari H; Nithianandam V; Battaglia RA; Cicalo A; Sarkar S; Comjean A; Hu Y; Leventhal MJ; Dong X; Feany MB
Genome Res; 2024 May; 34(4):590-605. PubMed ID: 38599684
[TBL] [Abstract][Full Text] [Related]
13. Quantitative and combinatory determination of in situ phosphorylation of tau and its FTDP-17 mutants.
Kimura T; Hosokawa T; Taoka M; Tsutsumi K; Ando K; Ishiguro K; Hosokawa M; Hasegawa M; Hisanaga S
Sci Rep; 2016 Sep; 6():33479. PubMed ID: 27641626
[TBL] [Abstract][Full Text] [Related]
14. Novel monoclonal antibodies targeting the microtubule-binding domain of human tau.
Croft CL; Moore BD; Ran Y; Chakrabarty P; Levites Y; Golde TE; Giasson BI
PLoS One; 2018; 13(4):e0195211. PubMed ID: 29608591
[TBL] [Abstract][Full Text] [Related]
15.
Hill SE; Beaulieu-Abdelahad D; Lemus A; Webster JM; Ospina SR; Darling AL; Martin MD; Patel S; Bridenstine L; Swonger R; Paul S; Blackburn R; Calcul L; Dickey CA; Leahy JW; Blair LJ
ACS Chem Biol; 2023 May; 18(5):1124-1135. PubMed ID: 37144894
[TBL] [Abstract][Full Text] [Related]
16. β-Arrestin2 oligomers impair the clearance of pathological tau and increase tau aggregates.
Woo JA; Liu T; Fang CC; Castaño MA; Kee T; Yrigoin K; Yan Y; Cazzaro S; Matlack J; Wang X; Zhao X; Kang DE; Liggett SB
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):5006-5015. PubMed ID: 32071246
[TBL] [Abstract][Full Text] [Related]
17. Differential compartmental processing and phosphorylation of pathogenic human tau and native mouse tau in the line 66 model of frontotemporal dementia.
Lemke N; Melis V; Lauer D; Magbagbeolu M; Neumann B; Harrington CR; Riedel G; Wischik CM; Theuring F; Schwab K
J Biol Chem; 2020 Dec; 295(52):18508-18523. PubMed ID: 33127647
[TBL] [Abstract][Full Text] [Related]
18. Disentangling tau: One protein, many therapeutic approaches.
Lane-Donovan C; Boxer AL
Neurotherapeutics; 2024 Mar; 21(2):e00321. PubMed ID: 38278659
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of nanobodies that inhibit seeding of Alzheimer's patient-extracted tau fibrils.
Abskharon R; Pan H; Sawaya MR; Seidler PM; Olivares EJ; Chen Y; Murray KA; Zhang J; Lantz C; Bentzel M; Boyer DR; Cascio D; Nguyen BA; Hou K; Cheng X; Pardon E; Williams CK; Nana AL; Vinters HV; Spina S; Grinberg LT; Seeley WW; Steyaert J; Glabe CG; Ogorzalek Loo RR; Loo JA; Eisenberg DS
Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2300258120. PubMed ID: 37801475
[TBL] [Abstract][Full Text] [Related]
20. Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits.
Velazquez R; Ferreira E; Tran A; Turner EC; Belfiore R; Branca C; Oddo S
Aging Cell; 2018 Aug; 17(4):e12775. PubMed ID: 29749079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
